| Name | Title | Contact Details |
|---|
HASELMEIER SARL is a Severna Park, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
XACT Robotics® is a privately held company focused on advancing the field of radiology by developing the world`s first and only hands-free robotic solutions that can significantly improve targeting accuracy, efficiency, and consistency in percutaneous radiology procedures. The company was founded in 2013 by Harel Gadot, a renowned entrepreneur in the MedTech robotics space, whose vision reimagined how image-guided percutaneous procedures are performed. At XACT, we embrace the philosophy of collaboration, tenacity, and extreme ownership. Our family culture empowers and inspires as we partner, develop, and execute meaningful technologies to make a difference in the lives of patients. Our company`s leadership is comprised of start-up, robotic, and disruptive technology experts with deep knowledge, vast experience and the diverse leadership skills required in the robotic market.
DCI International is a Newberg, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Sensiotec Inc., a medical device company, designs and delivers non-contact remote vital signs monitoring solutions in the United States. The company offers Virtual Medical Assistant that monitors patients, supporting evidenced-based medicine; and monitors heart and respiration rates and movement without pressure pads, sensors, or cuffs that touch the patient. The company serves acute and subacute care facilities, which include hospitals, surgery centers, outpatient clinics, skilled nursing, long-term care and hospice facilities. Sensiotec Inc. was founded in 2008 and is based in Atlanta, Georgia.
Median Technologies provides innovative imaging solutions and services to advance healthcare for everyone. As The Imaging Phenomics Company®, Median provides insights into novel therapies and treatment strategies. Our unique solutions, MediScan® for lesion management in patient care, Lesion Management Solution (LMS) for lesion detection, measurement and reporting in clinical trials, and our imaging phenotyping system iBiopsy®, together with our global team of experts, are advancing the development of new drugs and diagnostic tools to monitor disease and assess response to therapy. Median Technologies supports biopharmaceutical sponsors and healthcare professionals around the world in bringing new and targeted treatments to patients in need with an eye on reducing overall costs. This is how we are helping to create a healthier world. Founded in 2002, based in Sophia-Antipolis, France, with a US subsidiary in Boston, Median has received the label “Innovative company” by the BPI and is listed on Euronext Paris` Alternext market (ISIN: FR0011049824, ticker: ALMDT). The company is eligible for the PEA-PME SME equity savings plan setup and has received the label Pass French Tech Promotion 2016-2017.